Stock News

Drugmakers slash prices to be eligible for China's bulk-buy program
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 - CFO
FDA Risks Sacrificing Its Standards for Speed
Eli Lilly Interested in Bolt-On Acquisitions, CEO Says
Eli Lilly and Company -- Moody's announces completion of a periodic review of ratings of Eli Lilly and Company

As seen on...